V03AF07 • rasburicase • Various | All other therapeutic products | Detoxifying agents for antineoplastic treatment
Rasburicase is a medication used to treat high levels of uric acid in the blood (hyperuricemia) associated with tumor lysis syndrome, a common complication of cancer treatment. It works by converting uric acid into allantoin, a substance more easily excreted by the kidneys.
The medication is administered intravenously under the supervision of a specialist doctor, usually in a hospital setting. It is important to monitor uric acid levels and kidney function during treatment.
Side effects may include fever, nausea, vomiting, or injection site reactions. In rare cases, severe allergic reactions, such as anaphylactic shock, may occur, requiring immediate medical intervention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as G6PD deficiency, to ensure the safe use of rasburicase.
Substance: rasburicase
Date of last drug list: 01-07-2013
Commercial code: W51516001
Concentration: 1.5mg / ml
Pharmaceutical form: powder + solvent for concentrate perfusable solution
Quantity: 3
Product type: original
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.